Status:

COMPLETED

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

Lead Sponsor:

University of Zurich

Conditions:

Alveolar Echinococcosis

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles * Trial with medicinal product

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients with inoperable alveolar echinococcosis
  • With negative PET-CT
  • EmII/3-10 serology under long-term chemotherapy with benzimidazoles
  • Exclusion criteria:
  • Positive PET-CT
  • Positive EmII-3-10 Serology
  • No compliance
  • Reduced life expectancy
  • Pregnancy

Exclusion

    Key Trial Info

    Start Date :

    January 1 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2012

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT00658294

    Start Date

    January 1 2008

    End Date

    December 31 2012

    Last Update

    October 17 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Zurich

    Zurich, Switzerland